Form 8-K - Current report:
SEC Accession No. 0001104659-21-100067
Filing Date
2021-08-04
Accepted
2021-08-04 16:06:38
Documents
2
Period of Report
2021-08-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113965d16_8k.htm 8-K 18751
2 EXHIBIT 3.1 tm2113965d16_ex3-1.htm EX-3.1 146645
  Complete submission text file 0001104659-21-100067.txt   166665
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 211144016
SIC: 8731 Services-Commercial Physical & Biological Research